News Quantified

ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)

BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26

2/4

06:09 am

onc

Low

BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Citizens Highlights BeOne Medicines' (ONC) $3.8B Revenue Potential for 2025 [Yahoo! Finance]

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

BeOne Medicines (NASDAQ:ONC) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}